Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.
D000667:Ampicillin / Q000008:administration & dosage / Q000097:blood; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001777:Blood Coagulation; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood; D005337:Fibrin; D007275:Injections, Intravenous; D007612:Kanamycin / Q000008:administration & dosage / Q000097:blood; D007684:Kidney Tubules / Q000187:drug effects; D010068:Oxacillin / Q000008:administration & dosage / Q000097:blood; D011339:Probenecid / Q000494:pharmacology*; D011817:Rabbits; D013307:Streptomycin / Q000008:administration & dosage / Q000097:blood
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007612:Kanamycin; D000667:Ampicillin; D005337:Fibrin; D011339:Probenecid; D010068:Oxacillin; D013307:Streptomycin